Polymorphic expression of decay-accelerating factor in human colorectal cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 2, 2001, Pages 184-189

  Nakagawa, Masahiro ^a   Mizuno, Motowo ^a   Kawada, Mikihiro ^a   Uesu, Tokurou ^a   Nasu, Junichirou ^a   Takeuchi, Kazuaki ^a   Okada, Hiroyuki ^a   Endo, Yuichi ^b   Fujita, Teizo ^b   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CD55 (decay accelerating factor); Colon cancer; Complement regulators; O glycosylation

Indexed keywords

DECAY ACCELERATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN STABILITY; WESTERN BLOTTING;

EID: 0035105162     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02418.x     Document Type: Article

References (30)

1. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46)
2. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system
3. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb
4. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer
5. Detection of decay-accelerating factor in stool specimens of patients with colorectal cancer
6. Effects of O-linked glycosylation on the cell surface expression and stability of decay-accelerating factor, a glycophospholipid-anchored membrane protein
7. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas
8. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin)
9. Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells
10. Cytokine-stimulated release of decay-accelerating factor (DAF; CD55) from HT-29 human intestinal epithelial cells
11. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours
12. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement
13. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p561ck and p59fyn 1
14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
15. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
16. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor
17. Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line
18. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins
19. Identification of 5′-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression
20. Expression of messenger RNAs for complement inhibitors in human tissues and tumors
21. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b
22. Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells
23. Identification and quantification of complement regulator CD46 on normal human tissues
24. Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement
25. Mucin glycoproteins in neoplasia
26. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells
27. A family of UDP-GalNAc: Polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation
28. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: Immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family
29. Decay-accelerating factor: Biochemistry, molecular biology, and function